Obesity is consistently associated with worse overall survival in patients with early HER2 + breast cancer, but evidence on the link between obesity and advanced HER2 + breast cancer is heterogeneous [26–28]. This evidence concerns the gene ERBB2 and obesity due to melanocortin 4 receptor deficiency.